Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.
about
An oral formulation of efavirenz-loaded lactoferrin nanoparticles with improved biodistribution and pharmacokinetic profile.Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.Advances in nanomedicine drug delivery applications for HIV therapy.Functionalization of Cotton Fabrics with Polycaprolactone Nanoparticles for Transdermal Release of Melatonin.Enhancement of oral bioavailability of anti-HIV drug rilpivirine HCl through nanosponge formulation.
P2860
Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly(epsilon-caprolactone) nanoparticles by a spray-drying method.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly
@nl
Enhanced oral bioavailability ...... cles by a spray-drying method.
@en
type
label
Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly
@nl
Enhanced oral bioavailability ...... cles by a spray-drying method.
@en
prefLabel
Enhanced oral bioavailability of the antiretroviral efavirenz encapsulated in poly
@nl
Enhanced oral bioavailability ...... cles by a spray-drying method.
@en
P2093
P2860
P356
P1433
P1476
Enhanced oral bioavailability ...... icles by a spray-drying method
@en
P2093
Alejandro Sosnik
Christian Hocht
Diego A Chiappetta
Lebogang Katata
Lesego Tshweu
Lonji Kalombo
P2860
P304
P356
10.2217/NNM.13.167
P50
P577
2013-12-23T00:00:00Z